Country for PR: Hong Kong
Contributor: PR Newswire Asia (Hong Kong)
Thursday, April 28 2022 - 10:00
AsiaNet
Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards
SINGAPORE, April 28, 2022 /PRNewswire-AsiaNet/ --

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology 
leader, today announced that the company's mymobility(R) digital care 
management platform won "The Care Management Initiative of the Year" award at 
this year's Healthcare Asia Medtech Awards.

mymobility(R) is a digital care management platform that uses iPhone(R) and 
Apple Watch(R) or Android devices to help surgeons to deliver support and 
guidance to their patients, as well as to assist patients to prepare for joint 
replacement, by providing the patient the ability to take an active role in 
their personal care and recovery process. The app contains personalised care 
plans connecting patients with their orthopaedic surgeon and health 
practitioners before and after the surgical implantation. Patients have access 
to educational content, information on exercises and frequently asked questions 
on personal care to optimize their recovery from the surgery.

"We are absolutely delighted to be recognized by Healthcare Asia for the second 
consecutive year for our ZBEdge(TM) Connected Intelligence Suite," said Sang 
Yi, Group President Zimmer Biomet Asia Pacific. "As a result of the pandemic, 
the healthcare industry had to immediately adapt and act in response to an 
unprecedented situation. mymobility(R) has enabled patients to receive support 
and guidance through a connected experience."

mymobility(R) is part of Zimmer Biomet's ZBEdge(TM) Connected Intelligence 
Suite of digital and robotic technologies designed to deliver actionable 
insights with the goal of improving patient outcomes using data-powered 
clinical insights.

"Innovation has been key to Zimmer Biomet's growth, and we will continue to 
invest in new technologies that enable us to stay true to our mission to 
alleviate pain and improve the quality of life for people around the world," 
Sang Yi added.

About Zimmer Biomet 

Zimmer Biomet is a global medical technology leader with a comprehensive 
portfolio designed to maximize mobility and improve health. We seamlessly 
transform the patient experience through our innovative products and suite of 
integrated digital and robotic technologies that leverage data, data analytics 
and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is 
positioned to deliver the highest quality solutions to patients and providers. 
Our legacy continues to come to life today through our progressive culture of 
evolution and innovation.

For more information about our product portfolio, our operations in 25+ 
countries and sales in 100+ countries or about joining our team, visit 
www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at 
www.twitter.com/zimmerbiomet.


SOURCE: Zimmer Biomet
Translations

Japanese